News on Medial

🔥 1 person is talking about this

LambdaTest raises $38 Mn to scale QA platform KaneAI

EntrackrEntrackr · 12m ago
LambdaTest raises $38 Mn to scale QA platform KaneAI
Medial

Cloud-based testing platform LambdaTest has secured $38 million in a funding round led by Avataar Ventures, with Qualcomm Ventures also participating. The fresh funding comes after a gap of more than 30 months for the Noida and San Francisco-based startup. This latest round brings the company’s total funding to $108 million, including a $45 million round in March 2022. Its early backers include Premji Invest, Peak XV, Telstra Ventures, Blume Ventures, and Leo Capital. LambdaTest was part of the fourth cohort of Peak XV’s accelerator program, Surge. LambdaTest plans to use the latest funds to enhance its AI-driven QA solutions, including its newly launched “AI Native QA Agent-as-a-Service” platform, KaneAI. Founded in 2017 by Asad Khan, the startup aims to revolutionize quality assurance (QA) through automation and AI. LambdaTest boasts a customer base of over 15,000 and claims to have executed more than 1.2 billion tests to date. KaneAI is designed to reduce manual testing efforts by up to 70% by automating test script generation and providing actionable insights. According to the company, its HyperExecute platform accelerates test resolution by 2.5x and detects errors 60% faster than traditional cloud grids. With 105% year-over-year growth, LambdaTest serves over 2.3 million developers and testers globally. In India, the firm’s operating revenue surged 53.6% to Rs 175.44 crore in FY24 from Rs 114.22 crore in the previous fiscal year. Its profit stood at around Rs 18 crore. However, the company did not disclose its global financial numbers. BrowserStack, Perfecto, and Testsigma are some of LambdaTest’s direct or indirect competitors.

Related News

CrisprBits raises $3 Mn led by Spectrum Impact

EntrackrEntrackr · 13d ago
CrisprBits raises $3 Mn led by Spectrum Impact
Medial

CrisprBits raises $3 Mn led by Spectrum Impact CrisprBits will deploy the new funds to scale commercialisation of its PathCrisp molecular diagnostics platform and expand manufacturing for tests in human health, food safety and animal health. Bengaluru-based biotechnology startup CrisprBits has raised $3 million from founders, angels and family offices, taking its valuation to $12 million. The Pre-Series A round was led by Spectrum Impact, the family office of Rajendra Gogri, Chairman and Managing Director of Aarti Industries. Existing backers including Vijay Alreja Family Office (VJ Technologies Group) also participated, along with new investors from the promoter family of HBL Engineering. The company had earlier raised capital from founders, VJ Technologies Group and C-CAMP. CrisprBits will deploy the new funds to scale commercialisation of its PathCrisp molecular diagnostics platform and expand manufacturing for tests in human health, food safety and animal health. The company is also developing a CRISPR-driven strain engineering platform, starting with biofuel production processes. Founded by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra and Aditya Sarda, CrisprBits operates a 7300 sq ft CRISPR R&D and prototype development facility in Bengaluru. The company runs three platforms: PathCrisp for molecular diagnostics, EdiCrisp for gene editing and strain engineering, and CurieCrisp for preclinical and rare disease-focused therapeutics. Over the next six months, CrisprBits plans to expand its CRISPR diagnostic products to global markets including Africa and Latin America. It will further strengthen operations by scaling infrastructure and production capabilities at its diagnostics manufacturing facility. The firm also aims to build an AI-augmented strain engineering platform for sustainability applications.

Download the medial app to read full posts, comements and news.